Blueprints for ATP machinery will aid tuberculosis drug design

Gregory M. Cook () and Matthew B. McNeil

Nature, 2024, vol. 631, issue 8020, 278-280

Abstract: Structural insights into how anti-tuberculosis drugs interact with the enzyme that makes ATP in bacteria and humans pave the way for improved drug design to treat the disease and combat antimicrobial resistance.

Keywords: Antibiotics; Drug discovery; Structural biology (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-02094-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:631:y:2024:i:8020:d:10.1038_d41586-024-02094-1

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-02094-1

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().